Probiotics and prebiotics: where are we going?Gerald W. Tannock, editor Caister Academic Press, Wymondham, U.K., 2002 ISBN ISBN abbr. International Standard Book Number ISBN International Standard Book Number ISBN n abbr (= International Standard Book Number) → ISBN m : 0-9542464-1-1 Pages: 336 Price: $180 "Probiotics Probiotics Bacteria that are beneficial to a person's health, either through protecting the body against pathogenic bacteria or assisting in recovery from an illness. Mentioned in: Colonic Irrigation, Dysentery, Gastroenteritis and prebiotics have become part of the lexicon of food technologists," writes Gerald W. Tannock, editor of the provocative new book, Probiotics and Prebiotics: Where Are We Going? Probiotics were defined by Fuller in 1989, as "live microbial feed supplements that beneficially affect the host animal by improving its intestinal microbial balance." The concept of probiotics is not new, however. Approximately 100 years ago, Elie Metchnikoff, the father of immunology, investigated intestinal microbes as causative agents in aging, a process he called "autointoxication au·to·in·tox·i·ca·tion n. Self-poisoning resulting from the absorption of waste products of metabolism, decomposed intestinal matter, or other toxins produced within the body. Also called endogenic toxicosis. ." He believed that lactic lactic /lac·tic/ (lak´tik) pertaining to milk. lac·tic adj. Of, relating to, or derived from milk. lactic pertaining to milk. acid-producing bacteria (such as those found in yogurt) would suppress the growth of more proteolytic pro·te·o·lyt·ic adj. Relating to, characterized by, or promoting proteolysis. proteolytic (pro″teolit´ik), adj , autointoxicating bacteria. Prebiotics have been defined as "nondigestible food ingredients (usually carbohydrates) that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon." Potential prebiotics have included bifidobacteria, indigenous microbes epidemiologically associated with long life and other healthful conditions. The concept of probiotics has been developing over recent decades, and the use of prebiotics extends this idea. Although the ideas are intriguing, the central theories to be tested and the tools necessary to test them have been lacking. This book contributes substantially to addressing these difficulties. The opening chapter, by Tannock, is rich in ideas and sets the appropriate tone for the rest of the book. The other nine chapters, by 20 other authors from seven countries, address both hypotheses and specifics in state-of-the-art reviews. The central issue in this field is the following: how can the metabolic activities of the bacterial population in the colon be manipulated to promote health? Rigorous scientific exploration of this question has been limited by two factors: the colonic biota biota /bi·o·ta/ (bi-o´tah) all the living organisms of a particular area; the combined flora and fauna of a region. bi·o·ta n. The flora and fauna of a region. (flora) is vast and also largely undefined. In consequence, many studies, fueled by commercial self-interest, have lacked the stringency necessary for true scientific advancement. Accordingly, a substantial portion of this book discusses the methods, current or being developed, that will help address these deficiencies. Improved methods hold the promise of better defining which bacteria are present, distinguishing how much the biota varies from person to person, and measuring how well persons respond to probiotics and prebiotics. Another important issue is exploring the relationship of the microbial biota and the host, especially the healthy host; such microecologic studies are critical to understanding potential microbial contributions to disease. Again, development of standard methods would permit these assessments; without extensive cataloging, we cannot establish the baseline. A third and related issue is defining conditions that might be ameliorated by probiotic pro·bi·ot·ic n. A dietary supplement containing live bacteria or yeast that supplements normal gastrointestinal flora, given especially after depletion of flora caused by infection or ingestion of an antibiotic drug. or prebiotic prebiotic nutrients that support growth and activity of bacteria, principally bifidobacteria, and resist absorption in the upper small intestine. Includes indigestible carbohydrates, inulins and lactulose. therapies. The authors provide a long list of such diseases, including colon cancer, inflammatory bowel disease inflammatory bowel disease n. Abbr. IBD Any of several incurable and debilitating diseases of the gastrointestinal tract characterized by inflammation and obstruction of parts of the intestine. , and some less obvious candidates such as osteoporosis and atopic atopic /atop·ic/ (a-top´ik) (ah-top´ik) 1. ectopic. 2. pertaining to atopy; allergic. atopic 1. displaced; ectopic. 2. pertaining to atopy. diseases (for example, asthma). Some researchers have hypothesized that these latter diseases result from a childhood deprived of specific pathogens, the "hygiene hypothesis." Use of probiotics and prebiotics has been advanced as one solution to that problem. In summary, Probiotics and Prebiotics is an important book, from which I have learned much. One deficiency, however, is the book's remarkable absence of discussion about the role of these agents in the selection of particular bacterial populations. The focus of the book, and of the field, is largely on metabolism, but any of the anticipated therapies, especially prebiotics, will select for particular bacterial species or phenotypes. A greater focus on the biology of selection in this milieu would have been helpful. Nevertheless, this limitation does not substantially reduce the great utility of this volume to those interested in ecology, microbiology, medicine, or nutrition. This book explores a field that is out of the mainstream of human biology and medicine but deserves to be more central. For a field often marked by hyperbole because of commercially based conflicts of interest, this book is appropriately subdued and scientifically balanced. The editor and authors should be credited for their scholarly approach. Martin J. Blaser Martin J. Blaser, MD is the Frederick H. King Professor of Internal Medicine, Chairman, Department of Medicine, and Professor of Microbiology at New York University School of Medicine. He is an established researcher in microbiology and infectious diseases. * * New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the School of Medicine, New York, New York, USA |
|
||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion